Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Roth

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Science Translational Medicine|February 8, 2013
Blocking NRG1 and other ligand-mediated Her4 signaling enhances the magnitude and duration of the chemotherapeutic response of non-small cell lung cancerGanapati V Hegde, Cecile C de la Cruz, Cecilia Chiu, et al.
Molecular Pharmaceutics|April 9, 2015
An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancerSteven R Leong, Wei-Ching Liang, Yan Wu, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Science Translational Medicine|February 8, 2013
Blocking NRG1 and other ligand-mediated Her4 signaling enhances the magnitude and duration of the chemotherapeutic response of non-small cell lung cancerGanapati V Hegde, Cecile C de la Cruz, Cecilia Chiu, et al.
Molecular Pharmaceutics|April 9, 2015
An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancerSteven R Leong, Wei-Ching Liang, Yan Wu, et al.
Pageof 2